"Our study provides a new direction to understand the whole evolutionary history of massive stars toward the formation of black hole binaries."

Massive supernova explosion may have created a binary black hole

"If they were purely made up of stars, they would be the densest galaxies in the universe."

James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise

Four astronauts are set to depart the International Space Station Wednesday amid a health concern. The unprecedented early departure will leave behind a skeleton crew.

4 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab

SpaceX's Crew-11 astronauts will leave the International Space Station today (Jan. 14) in the first-ever medical evacuation from the orbiting lab, and you can watch it live.

Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video)

Organ donations from the recently deceased dropped last year for the first time in over a decade, resulting in fewer kidney transplants, according to an analysis issued Wednesday that pointed to signs of public mistrust in the lifesaving system.  More than 100,000 people in the U.S. are on the list for an organ transplant.  The nonprofit Kidney Transplant Collaborative analyzed federal data and found 116 fewer kidney transplants were performed last year than in 2024.

Public mistrust linked to drop in deceased donor organ donations and kidney transplants

Jan 14 (Reuters) - AbbVie said on Wednesday it is seeking to expand its presence in the fast-growing market ​for obesity treatments, leaning on the weight-loss drug it licensed ‌last year from Danish biotech Gubra. Gubra's drug, GUBamy, mimics the hormone amylin and could ‌be used as an alternative to popular GLP-1 drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound to help people lose more weight with fewer side effects.

AbbVie plans to build out its presence in obesity market

The FDA upgraded the earlier cheese recall to a Class I designation.

What to know about cheese voluntarily recalled in 20 states

NEW YORK, Jan 14 (Reuters) - U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion in 2023, driven by increased health insurance enrollment and a jump in use of medical

US healthcare spending soars to over $5 trillion in 2024

Jan 13 () - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ​accelerate drug discovery through artificial intelligence. The company said ‌it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion ‌Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.

Illumina unveils dataset to speed up AI-powered drug discovery

SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry ​increases its use of artificial intelligence to accelerate the discovery of ‌new drugs. The companies did not disclose financial terms.

AstraZeneca to acquire Modella AI to speed oncology drug research

By Sneha S K and Gnaneshwar Rajan Jan 13 (Reuters) - Thermo Fisher Scientific's pharmaceutical services business has won a ​number of contracts to help its customers move production ‌from Europe or Asia to the U., the medical equipment maker's CEO, ‌Marc Casper, said on Tuesday.

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

Here's how to lock in Paramount+'s current pricing before they raise their rates.

It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing

March arabica coffee (KCH26 ) on Tuesday closed up +4.20 (+1.18%). March ICE robusta coffee (RMH26 ) closed up +36 (+0.92%). Coffee prices settled higher on Tuesday amid concerns that excessive dryness in Brazil could lead to smaller coffee yields. Last Thursday, arabica rallied to a 1-month high due to...

Coffee Prices Finish Higher on Brazil Cop Concerns

Jan 12 () - Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant ​Narasimhan said at a major industry conference that kicked ‌off on Monday in San Francisco. "We are always looking for opportunities that fit ‌our core therapeutic areas," Narasimhan said at the J.

Novartis eyes more bolt-on acquisitions, CEO says

Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial ​insurance plans, the drugmaker's CEO Daniel O'Day said at ‌a major industry conference that kicked off on Monday in San Francisco. "CVS has ‌confirmed their coverage of Yeztugo as of January 1, putting us at more than 80% (insurer) coverage overall," O'Day said.

Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says

Jan 12 () - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at ​a major industry conference that kicked off on Monday in San Francisco. The ‌medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly ‌in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market.

Medtronic has 'significant firepower' for multiple acquisitions, executives say

Mattel announced a new Barbie doll, the first with autism, on Sunday.

Advocacy groups react after Mattel introduces 1st Barbie doll with autism

The head of the nation's most important financial institution has been the target of relentless criticism from President Trump.

Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.

Jan 12 () - Revvity said on Monday it expects ​its 2025 adjusted profit per ‌share to exceed its forecast of $4.90 ‌to $5, as the medical equipment maker benefits from renewed demand for contract research and diagnostics ⁠services.

Revvity says it will exceed 2025 profit forecast range

US EPA will reassess safety of herbicide paraquat, says its chief

Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for allegedly misusing its messenger RNA technology ‌in manufacturing their vaccines, a Bayer spokesperson confirmed. The patent infringement lawsuits said the companies ‌copied technology developed by Monsanto in the 1980s for strengthening mRNA in crops in order to stabilize the genetic material used in their vaccines.

Bayer sues COVID vaccine makers over mRNA technology

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively ​by healthcare research firm 3 Axis Advisors.

Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump

By Sneha S K and Sahil Pandey Dec 31 (Reuters) - The U. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the ​treatment of a rare hormonal disorder, the company said on Wednesday.

US FDA declines to approve Corcept's drug for rare hormonal disorder

March ICE NY cocoa (CCH26 ) today is down -178 (-2.93%). March ICE London cocoa #7 (CAH26 ) is down -129 (-2.95%). Cocoa prices are sharply lower today, posting 1-week lows. Improved weather in West Africa is weighing on cocoa prices today. Tropical General Investments Group said today that favorable...

Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices

Business Insider reached out to more than 75 major employers, including Walmart and Google, about their efforts to support aging workers.

How Google, Microsoft, Walmart, and other corporate giants are preparing for an aging workforce

A 1982 Lotus Esprit Turbo that has spent three decades sitting untouched in a barn is set to cross the auction block in the United Kingdom, offering collectors a rare look at long-term automotive neglect wrapped in iconic sports car design. The car, now coated in moss and other organic growth, has been entered into a classic and vintage vehicle auction held at the Haynes Motor Museum. The sale is being organized by Charterhouse, a Dorset-based auction house known for handling estate and specialt

Barn Stored Lotus Esprit Turbo Seen After 30 Years

SpaceX just set a new annual-launch record for the sixth year in a row, and the numbers are getting pretty silly.

SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025

US electric car manufacturer Tesla is aiming to increase in production at its factory in Grünheide near Berlin in 2026, despite the difficult market situation in Germany. Output already grew in each quarter of the past year as planned, plant manager André Thierig told dpa in a recent interview.

Tesla plans to expand production at German car plant

The European continent is teeming with EVs, and it’s never been easier to own and charge one. But everything is under China's shadow.

Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026

Tory Bruno, the longtime chief of the launch provider United Launch Alliance (ULA) has joined the competition at Blue Origin.

Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects

We saw quite a few milestones notched in the final frontier this year. But there were a number of failures as well, some of them quite dramatic.

12 times rockets and spacecraft crashed and burned in 2025

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video membership; dose decisions managed on a smartphone app; access made as easy as buying a pair of Nikes. This is their vision of the consumerization of weight-loss as drugmakers Novo Nordisk and Eli Lilly prepare to launch pill versions alongside their blockbuster injectable treatments and incr

Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s​

Adam Raine’s life hurtled toward tragedy soon after he began talking with ChatGPT about homework last fall. Their exchanges grew more consuming as the 16-year-old opened up to the chatbot about his suicidal thoughts, according to data analysis of the conversations shared with The Washington Post by attorneys for Adam’s parents.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. In January, the high school sophomore spent just under an ho

Business

Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video)

AbbVie plans to build out its presence in obesity market

What to know about cheese voluntarily recalled in 20 states

US healthcare spending soars to over $5 trillion in 2024

Illumina unveils dataset to speed up AI-powered drug discovery

AstraZeneca to acquire Modella AI to speed oncology drug research

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing

Coffee Prices Finish Higher on Brazil Cop Concerns

Novartis eyes more bolt-on acquisitions, CEO says

Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says

Medtronic has 'significant firepower' for multiple acquisitions, executives say

Advocacy groups react after Mattel introduces 1st Barbie doll with autism

Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.

Revvity says it will exceed 2025 profit forecast range

US EPA will reassess safety of herbicide paraquat, says its chief

Bayer sues COVID vaccine makers over mRNA technology

Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump

US FDA declines to approve Corcept's drug for rare hormonal disorder

Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices

How Google, Microsoft, Walmart, and other corporate giants are preparing for an aging workforce

Barn Stored Lotus Esprit Turbo Seen After 30 Years

Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump

SpaceX shatters its rocket launch record yet again — 165 orbital flights in 2025

Tesla plans to expand production at German car plant

Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026

Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects

12 times rockets and spacecraft crashed and burned in 2025

Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s​

74 suicide warnings and 243 mentions of hanging: What ChatGPT said to a suicidal teen

Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s